Exploring the 1,3-benzoxazine chemotype for cannabinoid receptor 2 as a promising anti-cancer therapeutic.
1,3-Benzoxazin-4-one
CB(2)
Cancer
Inflammation
Neurodegenerative disorders
Neuropathic pain
Journal
European journal of medicinal chemistry
ISSN: 1768-3254
Titre abrégé: Eur J Med Chem
Pays: France
ID NLM: 0420510
Informations de publication
Date de publication:
05 Nov 2023
05 Nov 2023
Historique:
received:
10
05
2023
revised:
12
07
2023
accepted:
13
07
2023
medline:
22
8
2023
pubmed:
22
7
2023
entrez:
21
7
2023
Statut:
ppublish
Résumé
The discovery of selective agonists of cannabinoid receptor 2 (CB
Identifiants
pubmed: 37478557
pii: S0223-5234(23)00613-X
doi: 10.1016/j.ejmech.2023.115647
pii:
doi:
Substances chimiques
Benzoxazines
0
Receptors, Cannabinoid
0
Receptor, Cannabinoid, CB2
0
Receptor, Cannabinoid, CB1
0
Cannabinoid Receptor Agonists
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
115647Informations de copyright
Copyright © 2023 Elsevier Masson SAS. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare no competing financial interest.